News
UBS upgraded Alkermes (NASDAQ:ALKS) to Buy from Neutral on Tuesday, citing prospects for Irish biotech’s orexin 2 receptor ...
John Lovallo, UBS homebuilding analyst, joins 'The Exchange' to discuss the current state of the homebuilder market, what to ...
Welcome to Barron's Advisor! Our articles are free to Barron's subscribers and wealth management professionals. To subscribe ...
Shares in UBS dropped 7% on Tuesday as analysts voiced concern about the impact of new government proposals to force the ...
Advisor headcount down at Bank of America, Osaic and UBS so far in 2025, Wolfe Research analyst says
Toward the end of last year, UBS said it was redrawing its pay plan for advisors and in 2025 would cut a bonus for teams that ...
Eli Lilly and Company (NYSE:LLY) may be affected by the CVS formulary change considering it could change how its medication, Zepbound, is viewed when compared to Wegovy. That said, despite possible ...
Randy Anderson worked as a broker for nearly 25 years without a complaint before being accused of making unauthorized trades ...
Baxter International Inc. (NYSE:BAX) is one of the 12 best healthcare stocks to buy now. On June 11, UBS reiterated a ...
“Assuming U.S./China tariffs remain at their current levels, we expect CSI 300 A-share EPS to grow 6% YoY in 2025,” UBS ...
RBC Wealth Management recruited three financial advisors overseeing approximately $1.1 billion in combined client assets from ...
Newly-proposed rules on how to value deferred tax assets will likely be introduced gradually, UBS Group AG Chief Financial ...
UBS Group is continuing its focus on expenses in its United States wealth management franchise, including advisor pay, as the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results